Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Cupissol

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Neuro-Chirurgie|September 22, 2014
[Locoregional treatments of brain metastases for patients with metastatic cutaneous melanoma: French national guidelines]V Lubrano, S Derrey, G Truc, et al.
European Journal of Cancer (Oxford, England : 1990)|December 14, 2019
A phase II of gemcitabine combined with pazopanib followed by pazopanib maintenance, as second-line treatment in patients with advanced leiomyosarcomas: A unicancer French Sarcoma Group study (LMS03 study)P Pautier, N Penel, I Ray-Coquard, et al.
ESMO Open|July 29, 2021
A single-arm multicentre phase II trial of doxorubicin in combination with trabectedin in the first-line treatment for leiomyosarcoma with long-term follow-up and impact of cytoreductive surgeryP Pautier, A Floquet, C Chevreau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 17, 2016
Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma: subgroup analysis of the LUX-Head & Neck 1 trialP M Clement, T Gauler, J P Machiels, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 1996
A double-blind, randomised comparison of the anti-emetic efficacy of two intravenous doses of dolasetron mesilate and granisetron in patients receiving high dose cisplatin chemotherapyB Audhuy, P Cappelaere, M Martin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 2021
A randomized phase III trial comparing trabectedin to best supportive care in patients with pre-treated soft tissue sarcoma: T-SAR, a French Sarcoma Group trialA Le Cesne, J-Y Blay, D Cupissol, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 9, 2017
Improved survival using specialized multidisciplinary board in sarcoma patientsJ-Y Blay, P Soibinet, N Penel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 26, 2017
Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) databaseS Salas, N Resseguier, J Y Blay, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Neuro-Chirurgie|September 22, 2014
[Locoregional treatments of brain metastases for patients with metastatic cutaneous melanoma: French national guidelines]V Lubrano, S Derrey, G Truc, et al.
European Journal of Cancer (Oxford, England : 1990)|December 14, 2019
A phase II of gemcitabine combined with pazopanib followed by pazopanib maintenance, as second-line treatment in patients with advanced leiomyosarcomas: A unicancer French Sarcoma Group study (LMS03 study)P Pautier, N Penel, I Ray-Coquard, et al.
ESMO Open|July 29, 2021
A single-arm multicentre phase II trial of doxorubicin in combination with trabectedin in the first-line treatment for leiomyosarcoma with long-term follow-up and impact of cytoreductive surgeryP Pautier, A Floquet, C Chevreau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 17, 2016
Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma: subgroup analysis of the LUX-Head & Neck 1 trialP M Clement, T Gauler, J P Machiels, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 1996
A double-blind, randomised comparison of the anti-emetic efficacy of two intravenous doses of dolasetron mesilate and granisetron in patients receiving high dose cisplatin chemotherapyB Audhuy, P Cappelaere, M Martin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 2021
A randomized phase III trial comparing trabectedin to best supportive care in patients with pre-treated soft tissue sarcoma: T-SAR, a French Sarcoma Group trialA Le Cesne, J-Y Blay, D Cupissol, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 9, 2017
Improved survival using specialized multidisciplinary board in sarcoma patientsJ-Y Blay, P Soibinet, N Penel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 26, 2017
Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) databaseS Salas, N Resseguier, J Y Blay, et al.
Pageof 8